Limba
|
JMS-17-2 is a potent and selective small-molecule antagonist of CX3C chemokine receptor 1 (CX3CR1/GPR13)with IC50 of 0.32 nM. JMS-17-2 is used in the research of metastatic disease in breast cancer patients.
Price | 1.152,00 RON (preturile sunt fara TVA) |
---|---|
Description |
JMS-17-2 is a potent and selective small-molecule antagonist of CX3C chemokine receptor 1 (CX3CR1/GPR13)with IC50 of 0.32 nM. JMS-17-2 is used in the research of metastatic disease in breast cancer patients. |